DK0874853T3 - Fremgangsmåde til fremstilling af cefdinir - Google Patents

Fremgangsmåde til fremstilling af cefdinir

Info

Publication number
DK0874853T3
DK0874853T3 DK96943357T DK96943357T DK0874853T3 DK 0874853 T3 DK0874853 T3 DK 0874853T3 DK 96943357 T DK96943357 T DK 96943357T DK 96943357 T DK96943357 T DK 96943357T DK 0874853 T3 DK0874853 T3 DK 0874853T3
Authority
DK
Denmark
Prior art keywords
cefdinir
pct
date
preparing
sec
Prior art date
Application number
DK96943357T
Other languages
Danish (da)
English (en)
Inventor
Gwan Sun Lee
Young Kil Chang
Jong Pil Chun
Joon Hyung Koh
Original Assignee
Hanmi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019950058694A external-priority patent/KR0174432B1/ko
Priority claimed from KR1019950058695A external-priority patent/KR0174431B1/ko
Application filed by Hanmi Pharmaceutical Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0874853T3 publication Critical patent/DK0874853T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
DK96943357T 1995-12-27 1996-12-26 Fremgangsmåde til fremstilling af cefdinir DK0874853T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1019950058694A KR0174432B1 (ko) 1995-12-27 1995-12-27 신규한 결정성 세프디니르 중간체 및 그의 제조방법
KR1019950058695A KR0174431B1 (ko) 1995-12-27 1995-12-27 세프디니르의 제조방법
PCT/KR1996/000250 WO1997024358A1 (en) 1995-12-27 1996-12-26 Process for preparation of cefdinir

Publications (1)

Publication Number Publication Date
DK0874853T3 true DK0874853T3 (da) 2002-09-23

Family

ID=26631527

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96943357T DK0874853T3 (da) 1995-12-27 1996-12-26 Fremgangsmåde til fremstilling af cefdinir

Country Status (9)

Country Link
US (1) US6093814A (de)
EP (1) EP0874853B1 (de)
JP (1) JP3948628B2 (de)
AT (1) ATE218572T1 (de)
DE (1) DE69621649T2 (de)
DK (1) DK0874853T3 (de)
ES (1) ES2175167T3 (de)
PT (1) PT874853E (de)
WO (1) WO1997024358A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883247A (en) * 1996-06-10 1999-03-16 Hoffmann-La Roche Inc. Preparation of cephem and isooxacephem derivatives
AT405283B (de) 1997-04-04 1999-06-25 Biochemie Gmbh Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
JP4544692B2 (ja) * 2000-04-13 2010-09-15 大塚化学株式会社 3−ビニル−セフェム化合物の製造方法
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
ITMI20012364A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Processo di sintesi della cefixima via alchil-o arilsolfonati
JP2005516011A (ja) * 2001-12-13 2005-06-02 ランバクシー ラボラトリーズ リミテッド 結晶二水化セフニディールカリウム
MXPA04010627A (es) * 2002-04-26 2005-02-14 Ranbaxy Lab Ltd Proceso para la preparacion de cefdinir.
ITMI20020913A0 (it) * 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
DE60336331D1 (de) * 2002-08-13 2011-04-21 Sandoz Ag Ein cefdinir-zwischenprodukt
ITMI20022076A1 (it) * 2002-10-01 2004-04-02 Antibioticos Spa Sali di intermedi del cefdinir.
CA2520083A1 (en) * 2003-03-24 2004-10-07 Acs Dobfar S.P.A. Novel crystal of 7-[2-[(2-aminothiazol-4-yl)-2-hydroxyiminoacetamide-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) and method for preparation thereof
WO2004104010A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Crystalline form of cefdinir
US20050137182A1 (en) * 2003-06-02 2005-06-23 Ramesh Dandala Novel crystalline form of cefdinir
US20040242556A1 (en) * 2003-06-02 2004-12-02 Ramesh Dandala Novel crystalline form of cefdinir
US20050059818A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Polymorph of a pharmaceutical
US20050113355A1 (en) * 2003-09-12 2005-05-26 Duerst Richard W. Cefdinir pyridine salt
US20050059819A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Cefdinir pyridine salt
US20060211676A1 (en) * 2004-03-16 2006-09-21 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060142261A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060142563A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
US20060069079A1 (en) * 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
WO2006010978A1 (en) * 2004-06-30 2006-02-02 Wockhardt Limited Cefdinir polymorphic forms, and imidazole salt
WO2006018807A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Crystalline forms of cefdinir
MX2007006018A (es) * 2004-11-30 2007-06-07 Astellas Pharma Inc Suspension farmaceutica oral novedosa de cristal de cefdinir.
WO2007053723A2 (en) * 2005-10-31 2007-05-10 Teva Pharmaceutical Industries Ltd. Process for the preparation of cefdinir
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
US8466096B2 (en) * 2007-04-26 2013-06-18 Afton Chemical Corporation 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions
ITMI20071628A1 (it) * 2007-08-06 2007-11-05 Acs Dobfar Spa Sintesi di 3-alchenilcefalosporine e nuovi intermedi utili ad esse correlati
KR101058135B1 (ko) * 2008-04-04 2011-08-24 대웅바이오 주식회사 세프디니르 합성에 유용한 중간체 및 이를 이용하여세프디니르를 제조하는 방법
CN101481383B (zh) * 2008-12-31 2012-01-11 杭州奥默医药技术有限公司 头孢地尼酸式复盐化合物及制备方法
CN102020664B (zh) * 2010-11-30 2012-12-12 浙江工业大学 一种头孢地尼的合成方法
CN103319503A (zh) * 2013-06-09 2013-09-25 四川方向药业有限责任公司 一种头孢地尼的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162718C (da) * 1982-09-30 1992-05-11 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af 7-substitueret-3-vinyl-3-cephemforbindelser
IL113744A (en) * 1990-11-09 1998-06-15 Eisai Co Ltd History of 3-tufts and their preparation
TW212181B (de) * 1992-02-14 1993-09-01 Hoechst Ag
US5750682A (en) * 1994-07-22 1998-05-12 Antibioticos S.P.A. Glutaryl 7-ACA derivatives and processes for obtaining them

Also Published As

Publication number Publication date
ES2175167T3 (es) 2002-11-16
JP2000502700A (ja) 2000-03-07
WO1997024358A1 (en) 1997-07-10
JP3948628B2 (ja) 2007-07-25
ATE218572T1 (de) 2002-06-15
DE69621649D1 (de) 2002-07-11
US6093814A (en) 2000-07-25
DE69621649T2 (de) 2002-09-19
EP0874853A1 (de) 1998-11-04
EP0874853B1 (de) 2002-06-05
PT874853E (pt) 2002-09-30

Similar Documents

Publication Publication Date Title
DK0874853T3 (da) Fremgangsmåde til fremstilling af cefdinir
DE59108707D1 (de) Verfahren zur Herstellung von Oxetanonen
AU572130B2 (en) 4-phenylamino pyrimidines
AU2958497A (en) Preparation of polyalkeneamines
DK307289D0 (da) Pyrimidinderivater
DK0619806T3 (da) Fremstilling af substituerede piperidiner
DK0865498T3 (da) Fremgangsmåde til fremstilling af substituerede arylmælkesyreholdige cyclodepsipeptider med 24 ringatomer
ATE51617T1 (de) Verfahren zur herstellung von 4-phenyl-pyrrolderivaten.
DE60228724D1 (de) Verfahren zur herstellung von beraprost und dessen salzen
BR0009453B1 (pt) processo para a preparação de um composto.
DE69109913D1 (de) Cephalosporinzwischenverbindungen, Verfahren zu ihrer Herstellung sowie zur Herstellung ihrer Endprodukte.
GR3029590T3 (en) Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
ES8500742A1 (es) Procedimiento para la preparacion de derivados de acido fenilacetico
ES2134971T3 (es) Derivado de acido octahidro-2-naftaleno-carboxilico, su produccion y uso.
DK0725785T3 (da) Fremgangsmåde til fremstilling af rufloxacin af deraf
DK0555283T3 (da) Mellemprodukter ved fremstillingen af 4,5-difluoranthranilinsyre